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ABSTRACT 
 
 
Background: Nearly 50% of people with heart failure do not adhere to their 
medication regimens, leading to increased health care costs and poor patient outcomes. The 
purpose of this study was to examine the feasibility and acceptability of a 
SystemCHANGE™ intervention in improving medication adherence in older adults with 
heart failure. 
Methods: Adults 50 or older with heart failure who self-administer diuretics were 
screened for two months using electronic monitoring to determine baseline adherence 
scores. If adherence scores were below 88%, the participant was randomized into either the 
SystemCHANGE™ or attention control group. The attention control group received 
education using American Heart Association heart failure brochures. The 
SystemCHANGE™ intervention consisted of changing the individual’s environment by 
incorporating medication taking into existing routines, using small experiments with 
feedback, and receiving support from people who impact routines. Demographics, 
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medication adherence scores using a medication events monitoring system (MEMS), and 
acceptability and feasibility measures were collected throughout the study and analyzed.    
Results: Thirty participants were enrolled in the study. Sixteen participants had 
medication adherence rates greater than 88%, therefore exiting the study. Eleven participants 
did not complete the screening phase. Three participants were eligible to be randomized in 
the intervention or attention control group but only two agreed to continue with the study, 
leaving one participant in each group. The participant in the SystemCHANGE™ group did 
not complete the study. The screening sample was majority African American males 
(66.7%). The average adherence score of those who did not complete the screening phase 
was 65.6% versus 96% for those who did complete screening phase. Challenges were noted 
by participants in utilizing the MEMS caps during the screening phase.  
Conclusion: Future studies need to focus on understanding barriers and facilitators 
to participation in a research study of this nature. Lessons learned include using multiple 
recruitment sites, more education on MEMS use, and consideration of the Hawthorne effect. 
Major protocol revisions are needed to recruit and retain the proposed population.  
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CHAPTER 1 
INTRODUCTION  
 This dissertation is a mixed methods study examining the feasibility and 
acceptability of a SystemCHANGE™ intervention in improving medication adherence in 
older adults with heart failure. The dissertation contains five chapters. Chapter one 
introduces the problem of medication non-adherence in older adults with heart failure and 
summarizes the current state of the science in this research area. Chapter two is a published 
article reflecting a systematic review of intervention studies conducted to improve 
medication adherence in older adults with heart failure (Andrews, Russell, & Cheng, 2017). 
Chapter three describes methods utilized for this dissertation study. Chapter four includes 
results and a discussion of results. Chapter five discusses the conclusions of this dissertation.  
Older Adults with Heart Failure 
 Heart failure is characterized as cardiac muscle loss or dysfunction that leads to 
inadequate circulation throughout the body causing debilitating symptoms such as shortness 
of breath, fatigue, and fluid retention (Heart Failure Society of America, 2010). In the 
United States, 5.7 million people have heart failure, a number which will rise to over eight 
million by 2030 (Mozaffarian et al., 2016). One in nine deaths are from heart failure, while 
death occurs within five years of heart failure diagnosis in nearly 50% of people 
(Mozaffarian et al., 2016). Heart failure costs in 2012 were estimated at $30.7 billion and are 
predicted to rise to around $69.7 billion by the year 2030 (Mozaffarian et al., 2016). Heart 
failure is common in older adults (Alagiakrishnan, Banach, Jones, Ahmed, & Aronow, 
2013). Older adults make up a rapidly growing population. By the year 2030, it is estimated 
that one in five Americans will be 65 or older (U.S. Census Bureau, 2015).  
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Medication Non-Adherence 
 Adherence is “the extent to which a person’s behaviour – taking medication, 
following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider” (Sabaté, 2003, p. 18). Medication adherence 
is a process which entails initiation (taking the first dose), implementation (following the 
prescribed dosing regimen), discontinuation (stopping the medications), and persistence 
(time between first and last dose) (Vrijens et al., 2012). Medication non-adherence can be 
intentional or unintentional. Unintentional non-adherence includes forgetting a dose or 
misunderstanding the directions. Intentional non-adherence is when the patient decides not 
to take their medication for a variety of reasons (Bosworth, Oddone, & Weinberger, 2006).  
 Management of heart failure includes taking medications, regular exercise, stress 
reduction, keeping follow-up appointments, and sodium and fluid restrictions (Heart Failure 
Society of America, 2010). People with heart failure are also educated on self-monitoring of 
symptoms to know when to seek medical attention. Self-monitoring can include monitoring 
weight, edema, breathing patterns, tolerance to activity, and blood pressure (Hattori, Taru, & 
Miyawaki, 2011). Medications are crucial in heart failure and are used to alleviate 
symptoms, prolong life, and reduce admissions to the hospital (van der Wal & Jaarsma, 
2008). Medications included in heart failure guidelines consist of: angiotensin converting 
enzymes (ACE) inhibitors, angiotensin receptor blockers, beta-blockers, diuretics, 
aldosterone antagonists, and vasodilators (Heart Failure Society of America, 2010). These 
medications are taken routinely, and the regimen is complex. Some are taken once daily 
while others can be taken up to four times a day (Heart Failure Society of America, 2010). 
Heart failure is a progressive disease in which medications need to be taken indefinitely. As 
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the disease progresses, symptoms worsen, which can make medication adherence a further 
challenge (Heart Failure Society of America, 2010; Sabaté, 2003).  
 Despite the importance of medications, nearly 50% of people with heart failure do 
not adhere to their medication regimens (Sabaté, 2003; Zhang & Baik, 2014). Medication 
non-adherence leads to increased health care costs and poor patient outcomes. Non-
adherence to medication or dietary regimens causes more than one-third of hospital 
admissions of heart failure (HF) patients and costs around $300 billion a year (Bosworth et 
al., 2006; DiMatteo, 2004). Medication nonadherence causes around 10% of older adult 
hospital admissions (Col, Fanale, & Kronholm, 1990). A relationship has been found 
between a decrease in mortality rates in people who adhere to medications in heart disease 
(McDermott, Schmitt, & Wallner, 1997). Adherence to common heart failure medications 
are as follows: ACE inhibitors 77.8%, beta blockers 69.8%, and loop diuretics 69.8% (Viana 
et al., 2014). Medication non-adherence is a serious problem with multiple contributing 
factors.  
Factors Affecting Medication Adherence 
 The World Health Organization (WHO) proposes five factors affecting medication 
adherence including: patient barriers, therapy barriers, condition barriers, social/economic 
factors, and health system barriers (Sabaté, 2003). Patient factors include lack of skills, 
motivation, self-efficacy, and support. Therapy factors include dose frequency and side 
effects. Condition factors include disease specific symptoms. Social economic factors 
include socioeconomic status, education level, and support systems. Health system factors 
include lack of health care providers’ knowledge of adherence and lack of communication 
between patient and professional (Sabaté, 2003). 
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 A systematic review of determinants of medication adherence in heart failure 
patients found that many studies found barriers similar to the factors identified by WHO 
(Oosterom-Calo et al., 2013). One qualitative study that included individuals with 
hypertension, identified factors of non-adherence at each level of the socioecological model, 
which considers environmental factors that influence behavior, and also the factors of the 
WHO model (Holt, Rung, Leon, Firestein, & Krousel-Wood, 2014). The perception of 
individuals with heart failure is that medications improve symptoms, and they are likely to 
stop taking their medications if their symptoms do not lessen (Granger, 2004). Medications 
prescribed for heart failure such as diuretics have significant effects, such as frequent 
urination, leading this population to have different challenges to adherence compared to 
other populations. 
The more medications a patient is prescribed, the more difficulties they have 
adhering to medications (Pasina et al., 2014). Older adults are prescribed the highest number 
of medications of any population (Lo, 2001). In adults aged 60 or over, “76% used two or 
more prescription drugs and 37% used five or more” (Gu et al., 2010, p. 2). Not only are 
older adults prescribed more medications, but the regimen can be complex, including taking 
more than one dose a day, at different times of the day, in relation to meals, and via multiple 
routes. In one study of older adults, patients were taking an average of 16 doses per day and 
had eight special administration activities such as before meals or cutting the tablet in half 
(Griffiths, Johnson, Piper, & Langdon, 2004). Due to decreased metabolism, older adults are 
more prone to side effects and negative drug interactions, which are barriers to adherence 
(O’Donohue & Levensky, 2006). A decrease in sensory and motor skills also impact older 
adults’ abilities to hear instructions, read labels, open pill bottles, and remember medications 
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(O’Donohue & Levensky, 2006). Older adults can also have cognitive problems impacting 
adherence (Gellad, Grenard, & Marcum, 2011). Older adults with heart failure have a 
variety of adherence factors that need to be considered when formulating interventions.  
Medication Adherence Interventions 
Interventions to improve medication adherence fall into three main categories: 
educational, affective, and behavioral interventions. Educational interventions focus on 
conveying information to the patient (Bosworth et al., 2006). Educational intervention 
methods include oral, audiovisual, written, telephone, mailed, or emailed education 
(Peterson, Takiya, & Finley, 2003). Affective interventions focus on improving compliance 
through social support, feelings, or emotions. Affective interventions include counseling, 
family support, and supportive home visits (Bosworth et al., 2011). Behavioral interventions 
focus on changing behavioral patterns (Bosworth et al., 2011). Behavioral interventions 
include dosing change, packaging change, rewards, patient contracts, calendars, pill boxes, 
self-monitoring, and email or telephone reminders (Peterson et al., 2003). Behavioral 
interventions have been shown to improve adherence more than educational interventions 
(Conn et al., 2009; Dalem, Krass, & Aslani, 2012). Utilizing a combination of educational, 
behavioral, and affective interventions has been shown to have a greater impact on 
improving adherence than just one approach (Conn et al., 2009; Dalem et al., 2012; Roter et 
al., 1998).  
To date, there has been one systematic review and one meta-analysis exploring 
interventions to improve medication adherence in heart failure patients. Interventions with 
complex behavioral approaches, educational approaches, and simplification of the drug 
regimen did not impact adherence. Interventions that improved adherence focused on 
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monitoring symptoms and utilizing intensified patient care by pharmacists (Molloy, 
O’Carroll, Witham, & McMurdo, 2012). Interventions that focus on one adherence behavior 
at a time and focus on the patient rather than the health care provider had the greatest impact 
on medication adherence (Ruppar, Delgado, & Temple, 2015).  
One meta-analysis and six systematic reviews examined interventions improving 
medication adherence in older adults (Banning, 2009; Conn et al., 2009; Eijken, Tsang, 
Wensing, Smet, & Grol, 2003; George, Elliott, & Stewart, 2008; Higgins & Regan, 2004; 
Russell, Conn, & Jantarakupt, 2006; Schlenk, Bernardo, Organist, Klem, & Engberg, 2008). 
A variety of interventions were used. Decreasing the dosing frequency consistently 
improved adherence (Banning, 2009; Conn et al., 2009; George et al., 2008; Russell et al., 
2006). Special medication packaging such as blister packs also improved adherence (Conn 
et al., 2009; George et al., 2008; Higgins & Regan, 2004). Sending reminders via telephone 
also had a large effect on medication adherence (Eijken et al., 2003; Schlenk et al., 2008). 
Three reviews concluded that interventions tailored to the patient were more effective in 
improving medication adherence (Eijken et al., 2003; Higgins & Regan, 2004; Schlenk et 
al., 2008). 
Chapter two reviews medication adherence intervention studies conducted on older 
adults with heart failure which is the first review of this nature on this population (Andrews, 
Russell, & Cheng, 2017). Previous interventions that focused on the individuals and their 
beliefs and knowledge have had only small effects on improving outcomes (Conn, Ruppar, 
& Chase, 2016; Russell, Ruppar, & Matteson, 2011). There is a need for theory driven 
interventions (Ruppar, 2010) that focus on multiple environmental levels instead of just on 
the individual (Conn, Ruppar, Enriquez et al., 2016; Yap, Thirumoorthy, & Kwan, 2016). 
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The SystemCHANGE™ intervention focuses on changing the individual’s 
environment by incorporating medication taking into existing routines using small 
experiments with feedback, and receiving support from people who impact routines (Alemi 
& Neuhauser, 2005; Moore et al., 2006). This intervention has been utilized in previous 
research to improve sleep hygiene (Webel et al., 2013), increase exercise (Moore et al., 
2006), and improve eating behaviors (Alemi & Neuhauser, 2005). Testing this intervention 
in medication adherence (MA) research is in its early stages but it has been utilized in pilot 
studies on kidney transplant recipients and inflammatory bowel disease patients (Matteson-
Kome, Winn, Bechtold, Bragg, & Russell, 2014; Russell et al., 2011). This intervention also 
has potential to be translated into practice due to the short duration of the intervention that 
has been found effective in previous MA studies (Matteson-Kome et al., 2014; Russell et al., 
2011).  
Theory 
Many behavior theories describe, explain, and predict why people behave the way 
they do. These theories are utilized when formulating behavioral interventions to improve 
medication adherence (Bosworth et al., 2006). The majority of theory-driven interventions 
utilized in adherence research have been focused on the individual level with little impact on 
changing behaviors. The issue with theories that are focused on the individual is that they 
neglect environmental influences on behaviors. There is a need for theory-driven 
interventions that focus on multiple environmental levels instead of the individual (Ruppar, 
2010; Russell et al., 2011). The SystemCHANGE™ intervention utilizes the 
Socioecological Model and Plan-Do-Check-Act model as its framework and focuses on 
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changing one’s environment to change one’s behavior using personal continuous 
improvement.  
Bronfenbrenner’s socioecological model (1977) focuses on how environmental 
factors have an impact on one’s behavior. A major assumption of the Socioecological Model 
is that changes in the social environment will produce changes in the individual 
(Bronfenbrenner, 1977). A person’s ecological environment consists of the micro, meso, 
exo, and macro levels. The microsystem is the relationship between the person and their 
immediate environmental setting, including their home or workplace. The mesosytem 
consists of settings in which the person is found. The exosystem considers settings in which 
the person does not participate but impact the person who is contained in the setting. The 
macrosystem refers to culture and activities occurring in this culture (Bronfenbrenner, 
1977). 
The Plan-Do-Check-Act model is utilized for improving processes and quality 
improvement (Li, Li, & Li, 2014). The founder of this model was Dr. Edward Deming, who 
is considered the father of quality improvement (Deming, 2013). This model has also been 
referred to as the Plan-Do-Study-Act (PDSA) model and the model for improvement 
(Ogrinc, 2012). This model provides a framework for a change to occur within a system 
(Donnelly & Kirk, 2015). The first and most important step in the model is the “plan” step. 
During this step a problem is identified and a solution to the problem is proposed. The 
second step is “do,” in which the changes are carried out. The third step is “check” in which 
it is evaluated whether or not the change caused an improvement. The final step is “act,” 
when the change becomes permanent if it worked. If the plan did not work, other plans can 
be devised to retest (Deming, 2013; Donnelly & Kirk, 2015). This cycle can be repeated 
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until the desired outcome is achieved (Li et al., 2014). This model can be carried out by 
individuals, possibly leading to increased improvements (Li et al., 2014). 
 The SystemCHANGE™ intervention utilizes both the Socioecological model and 
PDCA model. Environmental routines and people who impact one’s environment are 
identified, and medication taking is incorporated into the individual’s routine and 
environment. The PDCA cycle is used to guide the intervention steps. The intervention starts 
with identifying solutions to improve medication adherence (plan), then the participant 
implements the solutions (do), and medication adherence is continuously monitored to 
evaluate if change led to an improvement (check and act). Additional cycles can occur if the 
initial solutions did not improve medication adherence (Russell, 2010). 
Conclusion 
 Medication non-adherence in older adults with heart failure is a significant problem. 
Factors influencing medication adherence are well known. Future studies attempting to 
improve medication adherence need to address gaps noted in previous intervention studies. 
The purpose of this study was to examine the feasibility and acceptability of a 
SystemCHANGE™ intervention in improving medication adherence in a highly prevalent 
population of older adults with heart failure. The SystemCHANGE™ intervention fills voids 
in previous adherence research by having a theoretical underpinning and focusing on the 
environment in which the individual is functioning using a continuous improvement 
approach. This research study provides knowledge to inform the protocol for future fully 
powered studies.  
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CHAPTER 2 
LITERATURE REVIEW 
 *Chapter two is a systematic review of intervention studies to improve medication 
adherence in older adults with heart failure. This review was published in the Journal of 
Gerontological Nursing. 
Introduction  
More than 5 million individuals in the United States have heart failure and this 
number is predicted to increase to 8 million by the year 2030 (Go et al., 2014). Heart failure 
can negatively impact quality of life due to debilitating symptoms such as fatigue, fluid 
retention, and shortness of breath (Heart Failure Society of America, 2010). One in nine 
deaths documented on death certificates is from heart failure, and death occurs within five 
years of heart failure diagnosis in approximately 50% of individuals (Go et al., 2014). Heart 
failure is also costly, accounting for approximately $30.7 million in 2012 (Go et al., 2014).  
 Management of heart failure includes taking medications, regular exercise, stress 
reduction, keeping follow-up appointments, and sodium and fluid restrictions (Heart Failure 
Society of America, 2010). Medications are essential in heart failure treatment because they 
lessen symptoms, decrease hospital admissions, and delay mortality (van der Wal & 
Jaarsma, 2008). Despite the importance of medications, approximately 50% of the heart 
failure population does not adhere to medication regimens (Zhang, Wu, Fendrick, & 
Baicker, 2013). Adherence is defined as “the extent to which a person’s behaviour – taking 
medication, following a diet, and/or executing lifestyle changes, corresponds with agreed 
recommendations from a health care provider” (Sabaté, 2003, p. 18). Nonadherence to 
medication or dietary regimens causes more than one-third of hospital admissions in patients 
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with heart failure (Bosworth et al., 2006). Individuals with heart failure who are adherent to 
medications have a $8,881 reduction in annual medical spending (Roebuck, Liberman, 
Gemmill-Toyama, & Brennan, 2011).  
 Despite substantial research focused on improving medication adherence, 
nonadherence remains a significant problem (Sabaté, 2003). Interventions can increase 
medication adherence but there is still a need for additional research to improve intervention 
effectiveness (Conn et al., 2009; Sabaté, 2003).  
Heart failure is common in older adults (Alagiakrishnan et al., 2013) and those with 
heart failure are prescribed complex medication regimens, making adherence particularly 
challenging in this population (Griffiths et al., 2004). The World Health Organization 
proposes five factors affecting medication adherence including: patient related barriers, 
therapy related barriers, condition related barriers, social/economic factors, and health 
system barriers (Sabaté, 2003). Heart failure leads to debilitating symptoms, and 
medications, such as diuretics, have significant side effects that cause this population to face 
different challenges to adherence than others (Heart Failure Society of America, 2010). 
Patients with heart failure believe medications decrease symptoms and may stop taking their 
medications if they do not lesson symptoms (Granger, 2004). Additional barriers to 
medication adherence that older adults face, making them different than other age groups, 
include cognitive level, forgetfulness, and complexity of medication regimens (Gellad et al., 
2011; Siabani, Leeder, & Davidson, 2013). It is crucial to consider these factors when 
formulating interventions to improve adherence.  
 The purpose of the current review was to summarize interventions designed to 
improve medication adherence in older adults with heart failure. To the current authors’ 
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knowledge, no report has systematically reviewed interventions to improve medication 
adherence in this population. The review included intervention studies with only older adult 
populations, making it different from previous reviews (Molloy et al., 2012). Older adults 
have different challenges to adherence, such as complex medication regimens, possible 
financial issues due to retirement, and possible need for help with medication taking, making 
it crucial to study this population separately (Yap et al., 2016). By identifying promising 
interventions, knowledge can guide future research and practice. Improving medication 
adherence in the growing older adult population can have a significant impact on health 
(Sabaté, 2003). 
Methods 
 A systematic review method was used following Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) guidelines to summarize the results of 
multiple studies exploring the effectiveness of interventions to improve medication 
adherence in older adults with heart failure. PRISMA guidelines comprise a 27-item 
checklist and flow diagram depicting records identified, and included and excluded studies. 
The guidelines were established to improve transparency and clarity of systematic reviews 
and meta-analyses (Moher, Liberati, Tetzlaff, & Altman, 2009).  
Search Strategies 
A comprehensive search was completed with assistance from a health science 
librarian. Databases searched included PubMed (1940-2015), CINAHL (1982-2015), 
PsycINFO (1806-2015), and Embase (1980-2015). There was no date restriction; articles 
from the database foundation date to July 2015 were included. Reference lists were also 
searched to identify additional studies. Keywords used included: adherence, compliance, 
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persistence, concordance, nonadherence, non-adherence, noncompliance, non-compliance, 
heart failure, cardiac failure, heart decompensation, myocardial failure, cardiomyopath*, 
pharmaceutic*, prescript*, medicat*, medicine, medicines, drugs, intervention*, random*, 
control*, clinical*, and trial*.  
Eligibility Criteria  
 Only higher level evidence designs of randomized controlled trials (RCTs) or quasi-
experimental designs were included. Inclusion criteria were: intervention study, medication 
adherence measured as the primary or secondary outcome, inclusion criteria of diagnosis of 
heart failure, and participants 45 or older. Previous research of older adults with heart failure 
used a wide range of age criteria to define older adults. Some studies defined older adults as 
60 or greater (Alagiakrishnan et al., 2013) whereas others defined them as 45 to 50 or older 
(Dickson et al., 2014; Goldstein et al., 2014; Hope, Wu, Tu, Young, & Murray, 2004; 
Morrow et al., 2005). Because age at diagnosis of heart failure is decreasing (Go et al., 
2014), age 45 or older was selected for the current review for the findings to be more 
generalizable. Studies were excluded if they were not published in English or were 
dissertations or unpublished manuscripts.  
Trial Selection 
 The initial search yielded 5,204 articles. After duplicates were removed, 4,275 
articles remained. Articles were then screened by title and removed if the title included a 
different disease than heart failure; was a systematic review, literature review, or meta-
analysis; or focused on other adherence behaviors. This screening resulted in 337 articles 
remaining to be screened for eligibility. Eight studies met criteria for inclusion. The trial 
selection PRISMA chart can be found in Figure 1. 
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Figure 1. Prisma Flow Chart.  
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Data Extraction 
 Data were extracted from the eight selected studies by the author (A.M.A.) and 
verified by the coauthor (C.L.R.). Data extraction included author and year, 
purpose/design/theory, sample/setting, intervention description, measures/outcomes, results, 
strengths/limitations, and elements for quality assessment. The summarized data are shown 
in Table 1.   
Quality Assessment 
 Study quality was assessed using the Downs and Black scoring tool (Downs & 
Black, 1998) which was formulated for use in epidemiology studies but is useful for health 
science research. The tool comprises 27 items that consider reporting, external and internal 
validity, selection bias, and sample power. This tool was found to have high internal 
consistency (KR- 0.89), good criterion validity, and good test-retest (0.88) and inter rater 
reliability (0.75) (Downs & Black, 1998). Quality scoring was completed by two authors 
(A.M.A. and C.L.R.) and compared for differences. Differences were resolved by discussion 
and resulted in no unresolved quality scoring disagreements. Results of quality scoring can 
be found in Table 1.  
Results 
 Of the eight included studies, four were randomized controlled trials (Fulmer et al., 
1999; Goodyer, Miskelly, & Milligan, 1995; Murray et al., 2007; Rich, Gray, Beckham, 
Wittenberg, & Luther, 1996), three were pilot randomized controlled trials (Barnason et al., 
2003; Barnason, Zimmerman, Hertzog, & Schulz, 2010; Varma, McElnay, Hughes, 
Passmore, & Varma, 1999), and one used a quasi-experimental design without a control 
group (Goldstein et al., 2014). Quality scores ranged from 10 to 26, with an average score of  
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Table 1 
Data Extraction Summarized 
First 
Author 
(Year) 
Design  Sample 
(Attrition)  
 
Interventions/ 
Interventionist/ 
Duration 
 
Adherence 
Measurement  
 
Adherence 
Results  
Barnason 
(2010)  
Pilot RCT  40 (5%)  
 
 Education and 
counselling modules 
tailored to patient  
Nurse 
2-3 weeks after 
hospitalization 
 Brief 
Medication 
Questionnaire  
Intervention 
group had 
higher levels 
of medication 
adherence 
(p< 0.001)  
Barnason 
(2003)  
Pilot RCT  35 (0%)  
 
Home communication 
intervention device 
(assess symptoms, risk 
factor modification, 
self-care education, & 
positive 
reinforcement)  
Health Buddy & 
Nurse 
6 weeks  
Cardiovascular 
Risk Factor 
Modification 
Adherence  
No 
statistically 
significant 
differences 
between 
groups  
Fulmer 
(1999)  
RCT  60 (16%) Daily telephone call 
reminders & daily 
video-telephone call 
reminders  
Research assistants 
6 weeks 
MEMS caps  No 
statistically 
significant 
difference 
between the 
two 
intervention 
groups  
Goldstein 
(2014)  
Feasibility 
Quasi-
experimen
tal  
60 (8%) 4 groups: smartphone 
app for recording 
medication taking, 
smartphone reminder 
app, pillbox (no 
reminder) and pillbox 
with reminder  
Research assistants 
28 days 
Bin opening or 
self-report on 
app  
Device type 
not 
associated 
with MA  
Goodyer 
(1995)  
RCT   100 (18%)  Medication 
counseling, calendar, 
and medication 
Tablet count  The 
counselled 
group had 
17 
information  
Pharmacist 
3 months  
statistically 
higher 
compliance 
than the 
control group 
(P < 0.001). 
First 
Author 
(Year) 
Design  Sample 
(Attrition)  
 
Interventions/ 
Interventionist/ 
Duration 
 
Adherence 
Measurement  
 
Adherence 
Results  
Murray 
(2007)  
RCT  314 (14%)  Icon placed on 
medication bottle and 
instruction sheet, 
written and verbal 
education 
Pharmacist 
9 months  
MEMS and 
refill adherence 
medication 
possession ratio  
The 
intervention 
group had a 
statistically 
higher refill 
adherence 
than the 
control group 
(P=0.007). 
Rich 
(1996)  
RCT 156 (0%)  Teaching, medication 
simplification, contact 
by nurse regularly 
after discharge  
Nurse, dieticians, 
social worker, 
pharmacist, home 
health nurses 
During hospital 
admission and 30 days 
post-hospitalization  
Pill counts  The 
intervention 
group had 
statistically 
higher MA 
than the 
control group 
(p= 0.003). 
Varma 
(1999)  
Pilot RCT  83 (40%)  Education, use of 
diary cards, 
medication 
simplification  
Pharmacist 
12 months  
Self- report and 
drug use 
profiles  
The 
intervention 
group had 
statistically 
higher 
compliance 
with drug 
therapy (p= 
0.039). 
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17. Results of quality scoring can be found in Table 2. Study publication years ranged from 
1995 to 2014 and sample sizes ranged from 35 (Barnason et al., 2003) to 314 participants 
(Murray et al., 2007). Mean age of participants ranged from 62 (Murray et al., 2007) to 84.5 
(Goodyer et al., 1995). Only one study attempted to include only nonadherent patients 
(Barnason et al., 2010). The studies were performed in the United States (N=6) (Barnason et 
al., 2003; Barnason, Zimmerman, Hertzog, & Schulz, 2010; Fulmer et al., 1999; Goldstein et 
al., 2014; Murray et al., 2007; Rich et al.,1996), Northern Ireland (N=1) (Varma et al., 
1999), and the United Kingdom (N=1) (Goodyer et al., 1995).  
 Interventionists included pharmacists (Goodyer et al., 1995; Murray et al., 2007; 
Rich et al., 1996; Varma et al., 1999), RNs (Barnason et al., 2003; Barnason et al., 2010; 
Rich et al., 1996), research assistants (N=2) (Fulmer et al., 1999; Goldstein et al., 2014), 
dietitians, and social workers (Rich et al., 1996). Intervention duration ranged from two 
weeks (Barnason et al., 2010) to 12 months (Varma et al., 1999). Participants were contacted 
one time (Goldstein et al., 2014; Varma et al., 1999), twice (Barnason et al., 2010; Rich et 
al., 1996), daily for six weeks (Barnason et al., 2010; Fulmer et al., 1999), every two weeks 
for three months (Goodyer et al., 1995), and every two months for one year (Murray et al., 
2007).  
 Only two studies used a theory-driven intervention, Bandura’s Social Cognitive 
theory (Barnason et al., 2003; Barnason et al., 2010) in which interacting influences shape 
new behaviors including personal factors and the physical and social environment (Bandura, 
2004). An assumption of this theory is that behaviors occur if a person has the attitude and 
ability to perform a behavior and has outcome expectations (Bandura, 2004). Only one of  
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Table 2 
Quality Scoring 
 
Barnason 
et al. 
(2010) 
Barnason 
et al. 
(2003) 
Fulmer 
et al. 
(1999) 
Goldstein 
et al. 
(2014) 
Goodyer 
et al. 
(1995) 
Murray 
et al. 
(2007) 
Rich 
et al. 
(1996) 
Varma 
et al. 
(1999) 
Reporting  7 5 4 7 4 8 7 6 
External 
validity 
1 1 1 1 1 3 1 1 
Internal 
validity- bias  
5 3 4 5 5 6 7 5 
Internal 
Validity- 
Confounding 
(selection 
bias)  
4 2 1 3 3 4 3 1 
Power  1 0 0 0 5 5 0 3 
Total 
Column  18 11 10 16 18 26 18 16 
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these two studies had a statistically significant improvement in medication adherence 
(Barnason et al., 2010) 
 Study intervention included educational, affective, or behavioral. Education was 
used in six studies (Barnason et al., 2003; Barnason et al., 2010; Goodyer et al., 1995; 
Murray et al., 2007; Rich et al., 1996; Varma et al., 1999). No interventions used education 
alone. Counseling, which is an affective intervention, was used in two studies (Barnason et 
al., 2010; Goodyer et al., 1995). Behavioral interventions were used in seven of the studies 
which included: decreasing dose regimens, telephone follow-ups, diary cards, and using an 
icon on the medication bottle that was also present on the medication information sheet, 
phone reminder, phone app recording of medication taking, pillboxes with reminders, and an 
intervention device (Barnason et al., 2003; Fulmer et al., 1999; Goldstein et al., 2014; 
Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996; Varma et al., 1999). Two studies 
utilized only one type of intervention (Fulmer et al., 1999; Goldstein et al., 2014), five 
studies utilized two types of interventions (Barnason et al., 2003; Barnason et al., 2010; 
Murray et al., 2007; Rich et al., 1996; Varma et al., 1999), and one study used all three types 
of interventions (Goodyer et al., 1995).  
 Medication adherence can be measured using objective measures (pill counts, 
electronic measuring devices, refill reports, supervised dosing, and blood drug levels) or 
subjective measures (self-report or provider assessments) (Bosworth et al., 2006; 
O’Donohue & Levensky, 2006). Four studies used objective measurements (Fulmer et al., 
1999; Goodyer et al., 1995; Murray et al., 2007; Rich et al., 1996), and two used subjective 
measures (Barnason et al., 2003; Barnson et al., 2010). Two studies used a combination of 
subjective and objective measures (Goldstein et al., 2014; Varma et al., 1999). One of these 
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two studies used objective measures in one group and subjective in another (Goldstein et al., 
2014). Four studies measured adherence immediately after the intervention (Goldstein et al., 
2014; Goodyer et al., 1995; Rich et al., 1996; Varma et al., 1999), one measured two weeks 
post-intervention (Fulmer et al., 1999) and three measured three months post-intervention 
(Barnason et al., 2003; Barnason et al., 2010; Murray et al., 2007).  
 Five studies (63%) documented a statistically significant improvement in medication 
adherence rates in the intervention group (Barnason et al., 2010; Goodyer et al., 1995; 
Murray et al., 2007; Rich et al., 1996; Varma et al., 1999). One study did not have a control 
group but had two intervention groups comparing two different reminder devices; there was 
no significant difference in adherence rates between devices (Goldstein et al., 2014). Two 
studies showed no significant difference in medication adherence rates (Barnason et al., 
2003). These three studies used technology in the intervention.  
Discussion 
 The purpose of this current article was to systematically review RCTs and quasi-
experimental intervention studies designed to improve medication adherence in older adults 
with heart failure. Five of eight studies (63%) found a statistically significant improvement 
in medication adherence in the intervention groups. All five studies used a combination of 
educational, behavioral, and affective interventions. These findings are consistent with 
previous research that suggests combined interventions have a greater impact on improving 
adherence (Conn et al., 2009; Dalem et al., 2012; Roter et al., 1998).  
Conn et al. (2009) found that behavioral interventions, including dosing 
simplification and reminder cues, had large adherence effect sizes in older adults. In the 
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current review, dosing simplification was utilized in two studies and reminder cues in two of 
the studies with statistically significant improvement in medication adherence.  
Pharmacists performed the intervention in four studies, showing significant 
improvement in medication adherence (Goodyer et al., 1995; Murray et al., 2007; Rich et 
al., 1996; Varma et al., 1999). A previous systematic review on interventions to improve 
medication adherence in the heart failure population also found the use of pharmacists as 
interventionists to be beneficial (Molloy et al., 2012). Two studies that did not show a 
statistically significant improvement in medication adherence both utilized technology 
interventions including a telephone device and smartphone application (Barnason et al., 
2003; Goldstein et al., 2014). Use of technology can be challenging in the older adult 
population due to physical changes and decreased use (Fletcher & Jensen, 2015). It is crucial 
to adapt technological interventions to meet the needs of older adults in order to be 
successful (Haugh, 2014). It was unclear in the two studies whether or not adaptations were 
made specific to older adults.  
 Quality scoring of the studies using the Downs and Black tool revealed that the 
studies are of average quality. All of the studies took place in clinics or hospitals, which is 
the typical setting in which people with heart failure receive care. Use of results is impacted 
due to small sample sizes, lack of generalizability, and average quality scoring. A prior 
systematic review on medication adherence interventions in heart failure patients also 
concluded there was a lack of high-quality evidence (Molloy et al., 2012). 
Only two studies utilized theory, emphasizing the need for more theory driven 
intervention studies (Banning, 2009; Conn et al., 2009; Ruppar, 2010; Russell et al., 2006). 
Of these two studies, one had a statistically significant improvement in medication 
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adherence. This intervention consisted of education and counseling that focused on the 
concepts of self-care and self-regulation (Barnason et al., 2010). The intervention in the 
study that did not show a significant improvement in adherence was comprised of a 
telephone device that focused on positive reinforcement to improve self-efficacy (Barnason 
et al., 2003). 
The longest follow-up of medication adherence was three months in three studies 
(Barnason et al., 2003; Barnason et al., 2010; Murray et al., 2007). Heart failure is a 
progressive disease in which medications will need to be taken indefinitely. As the disease 
progresses, symptoms worsen, which can make medication adherence a further challenge 
which supports the need for research studying the long term effect of interventions on 
medication adherence (Heart Failure Society of America, 2010; Sabaté, 2003).  
Four studies that significantly improved medication adherence utilized interventions 
that focused solely on medication adherence (Barnason et al., 2010; Fulmer et al., 1999; 
Murray et al., 2007; Rich et al., 1996; Varma et al., 1999). A recent meta-analysis found that 
focusing on only one health behavior at a time has larger effect sizes than focusing on 
multiple health behaviors (Ruppar et al., 2015). A change is more likely to occur when 
focusing on one behavior because it is easier for the individual to achieve.  
Strengths 
 Various strengths are noted in the intervention studies. The first strength is that seven 
of the eight studies (87.5%) used a RCT design, which is consider the gold standard for 
determining cause and effect and produces a high level of evidence (Polit, 2008). An 
additional strength is that six studies (83.3%) used objective measures of medication 
adherence, such as pill counts and electronic monitoring devices. Objective measures are 
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seen as gold standard as subjective measures tend to over report adherence (O’Donohue & 
Levensky, 2006). Other study strengths were noted during quality assessment. All studies 
had a clear aim, outcome, and inclusion criteria. The settings selected and interventionists 
used were representative of the general settings in which treatment was normally received. 
The interventions were also performed so that internal validity was maintained.  
Limitations 
 Limitations were noted in the current systematic review and reviewed studies. 
Despite using a systematic search process, some studies may have been missed. To 
minimize the chance of missing articles, a health sciences research librarian was used in the 
search. 
Limitations of the reviewed studies include no measurement of long-term effects, 
small samples that limited power, and four of the eight studies being published in the 1990s. 
There is a need for research studying long-term effects of interventions, which was not 
satisfied by the longest follow-up being three months. Three studies were pilot studies, 
which explains the small samples. However, only one study used a power analysis to 
determine sample size, increasing the risk of a type II error or accepting a false null 
hypothesis (Polit, 2008). No publication date restriction was used as inclusion criteria so that 
adequate study numbers could be included. One disadvantage of studies published more than 
ten years ago is that technology has advanced, making the interventions, such as using home 
telephones for reminders, out of date. 
 To prevent the “ceiling” effect, it is best to include only nonadherent patients in 
studies. Only one study attempted to include nonadherent patients. Adherence was not 
screened prior to the study but only participants at risk for low medication adherence (taking 
25 
five or more medications) were included, which is not a good measure of nonadherence 
(Barnason et al., 2010).  
Quality of the articles was average. Weaknesses noted in most studies regarded 
external validity which means it is possible results found in these studies cannot be 
generalizable to the larger population (Polit, 2008). There were also weaknesses noted in 
selection of participants in most of the studies. 
Implications 
 Current findings suggest guidance for future research studies. Medication adherence 
is challenging, particularly in older adults with heart failure. The population of patients with 
heart failure and older adults with heart failure possess different challenges to adherence, so 
studying the populations together is needed. Few studies exist using this combined 
population, making it difficult to make practice changes. Studies that use objective 
measures, larger samples, include solely nonadherent patients, and study long-term effects 
can enhance the medication adherence knowledge.  
 Only two studies reviewed used theories as a framework. Based on previous 
research, there is a need for additional interventions using theory (Ruppar, 2010). The Social 
Cognitive Theory was used in these two studies. This theory tends to focus more on the 
individual. A significant amount of research exists on improving medication adherence 
focusing on behavior changes at the individual level; however, there has not been an 
improvement in medication adherence (Haynes, Ackloo, Sahota, McDonald, & Yao, 2008; 
Kripalani, Yao, & Haynes, 2007; Russell et al., 2006). There is a need for interventions that 
focus on multi-level influences and consider environmental factors (Berben et al., 2015; 
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Russell et al., 2011). Linking medication taking to existing habits has been found to improve 
medication adherence (Conn, Ruppar, Enriquez, et al., 2016). 
 Improving adherence to medications that decrease symptoms and ultimately 
mortality should be a focus of all health-care providers. The current findings can help 
health-care providers identify useful interventions to improve medication adherence in older 
adults with heart failure and use them in practice. Adherence should be assessed and 
interventions using a combination of approaches should be implemented. Medication 
regimens should be simplified if clinically possible. An interdisciplinary approach including 
pharmacists should be followed. Changes in behavior should focus on one behavior at a 
time. A plan to use reminder cues should also be initiated. Although education alone does 
not improve adherence, it is an important component of combined interventions. Nurses can 
provide health teaching and information about intended effects of therapies, such as 
medications, which is part of the American Nurses Association’s standards of professional 
nursing practice (American Nurses Association, 2010). 
Conclusion  
Eight studies that trialed interventions to improve medication adherence in older 
adults with heart failure were reviewed. All five studies that showed significant 
improvement in medication adherence used combined intervention approaches. By 
reviewing strengths and limitations of these studies and comparing to the literature, guidance 
for future studies can be made. There is a need for interventions that use theory and 
intervention components found to be previously effective. Study designs can be improved by 
considering external validity, having larger sample sizes, measuring long term effects, and 
including nonadherent patients only.  
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Medication nonadherence in heart failure leads to poor patient outcomes, including 
symptom exacerbation, hospital admissions, and death (van der Wal & Jaarsma, 2008). 
Medication adherence is so crucial that the World Health Organization posed that improving 
medication adherence can have a greater effect on health than formulating new medical 
treatments (Sabaté, 2003). Formulating new interventions to improve medication adherence 
in older adults with heart failure and testing their effectiveness in high-quality research 
should be a priority.  
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CHAPTER 3 
METHODS 
Design 
A mixed methods study utilizing the SystemCHANGE™ intervention in non-
adherent older adults with heart failure was conducted to examine feasibility and 
acceptability. The purpose of this study was not hypotheses testing; instead, findings will be 
used to inform future protocol refinement of a fully powered study. The study consisted of 
three phases: screening, intervention, and maintenance which are described throughout this 
chapter. A diagram of the study design can be found in Appendix A. 
Aims/Research Questions 
The following aims were evaluated to meet the objectives of this study. 
Aim 1: To evaluate the feasibility of the SystemCHANGE™ intervention in HF 
older adults. 
Primary Research Questions: What are the recruitment rates in the study? Are the 
eligibility criteria sufficient or too restrictive? To what extent can the intervention 
procedures be implemented correctly? How appropriate is the timing and duration of the 
intervention? To what extent do the participants comply with the intervention? What are the 
attrition rates in the study? What is the extent of missing data? 
Exploratory Research Question: How effective is the intervention in improving 
medication adherence trends and heart failure outcome trends in this sample?  
Aim 2: To evaluate the acceptability of the SystemCHANGE™ intervention in older 
adults with HF. 
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Primary Research Questions: What are the time demands on the participants for 
visits and completing the survey? What are the challenges in using the medication event 
monitoring caps or wireless readers? Do participants feel the time spent in the study is too 
long, too short, or just right? What inconveniences does the survey or intervention place on 
the participant? To what extent do the participants remain blinded? Any other suggestions 
for improving the study? 
Setting 
Participants were recruited from Memorial Regional Health Services, which includes 
two hospitals in Southern Illinois, including urban and rural areas, that have a bed capacity 
of 220 and have 13,000 admissions annually. The screening, intervention, and maintenance 
phases of the study were conducted at the participants’ homes and over the telephone for 
both groups.  
Sample 
A convenience sampling approach was utilized to select eligible participants. 
Inclusion criteria were: 1) age 65 years or older, 2) HF diagnosis confirmed by an ejection 
fraction less than 40%, 3) prescribed diuretics, 4) self-administering medications, 5) able to 
open an electronic cap which is assessed by asking the participant if they have any problems 
opening pill bottle caps, 6) able to speak, hear, and understand English, 7) not hospitalized, 
and 8) no cognitive impairment. Cognitive impairment was determined by a score of 4 or 
greater on the 6-item mini-mental status exam which consists of orientation questions 
regarding day, month, and year and asking patients to repeat three words given prior to 
asking orientation questions.  
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Originally the sample size was planned for 40 participants being approached to 
participate in the study, but due to a consent rate lower than 80% which was found in similar 
studies (Barnason et al., 2010; Goldstein et al., 2014), 55 patients were asked to be in the 
study. This led to 30 consented participants enrolled in the screening phase.  
Screening Phase 
There was a two-month screening period in which adherence to diuretics was 
measured electronically utilizing medication event monitoring system (MEMS) caps. The 
MEMS cap is a computerized monitoring system in which a chip is located inside a cap and 
provides data of the date and time the pill bottle is opened (Park, Howie-Esquivel, & 
Dracup, 2015). The medication chosen to measure was diuretics, due to its lower adherence 
rate and higher association with patient outcomes (Viana et al., 2014). The first month of the 
two-month screening period was deleted to eliminate the possible influence of the 
Hawthorne effect. Participants with an adherence rate of 88% or greater exited the study. An 
adherence rate of 88% was selected because negative health outcomes can occur if 
adherence rates fall below 88% in the HF population based on a study measuring heart 
failure medication adherence using MEMS (Wu et al., 2009).  
Randomization 
Participants with adherence rates less than 88% after the two-month screening period 
were randomly allocated to either the attention control group receiving general HF education 
or the SystemCHANGE™ intervention group on a 1:1 ratio using a computer-generated 
randomization list. Participants were blinded to group assignments.  
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Independent Variables 
SC Intervention 
The SystemCHANGE™ intervention utilizes the Socioecological Model and Plan-
Do-Check Act model as its framework and focuses on changing the individual’s 
environment to change behavior using small experiments with feedback (Alemi & 
Neuhauser, 2005; Moore et al., 2006). A major assumption of the Socioecological Model is 
that changes in the social environment will produce changes in the individual 
(Bronfenbrenner, 1977).  
SC Training 
The principal investigator (PI), who is a registered nurse, delivered the intervention 
to all participants in the intervention following a protocol checklist (see Appendix B). The 
PI received extensive training on the intervention through taking doctoral courses on the 
Socioecological model and SystemCHANGE™. The PI also was part of a research team of 
experts in SystemCHANGE™ and observed multiple deliveries of the intervention and 
practiced extensively, receiving feedback from the experts.  
Steps of the Intervention 
Step 1: Initial visit. During the initial home visit, the PI and participant introduced 
themselves, and the intervention was described. The MEMS report from the screening 
period was reviewed with the participant. Identification of important people involved in 
medication taking in the participant’s life was determined utilizing the Important People 
Form (see Appendix C). Environmental routines that were daily, weekly, and monthly were 
identified using the Routines Form (see Appendix D). Any routines associated with 
medication taking were discussed. These routines were then placed in the Life Cycles Form 
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(see Appendix E) to help the participant explore connections among the routines and how 
they impacted medication taking. Solutions to improve medication taking were determined 
collaboratively by the PI and participant and added to the Possible Solutions Form (see 
Appendix F). 
Step 2: Incorporate system-wide solution into existing routine. The participant 
discussed the two system-wide solutions identified with their important person prior to the 
phone call occurring during week 1 to ensure the important person agreed with solutions and 
then started implementing solutions. If no important person was identified, solutions were 
implemented after the home visit. The MEMS Wireless Reader System was installed, and 
participants were shown how to use it. The MEMS reader wirelessly transmits adherence 
data using cellular connections into a database that calculates medication adherence scores 
and formulates adherence reports. The participant continued to use the MEMS. 
Step 3: Data collection and evaluation. During the one-month phone call, the PI 
and participant discussed the MEMS report from the previous month that was mailed to the 
participant and whether or not solutions were working or if new solutions needed to be 
implemented (see Appendix G). The participant continued to implement the solutions and 
use the MEMS and MEMS diary, recording any accidental openings or early openings 
during the intervention phase. During the two-month phone call, improvements made were 
discussed with participant. The participant continued to use the MEMS for the one-month 
maintenance phase and then received a phone call reminding them to return the MEMS via 
mail. They were also asked feasibility/acceptability questions at the conclusion of study. 
Participant contacts with descriptions are found in Table 3. 
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Table 3 
Intervention Group 
Timing Method/Content 
Baseline (~1hr) Home visit/ Review MEMS from screening, Describe 
Intervention, Identify Important People, Routines, Cycles of 
Routines, and Possible Solutions, install Home Link System 
 
Week 1 (~ 15min) Phone call/Implement Solutions if not already done so  
One month (~ 15min) Phone call/Mail monthly MEMS report to participant, Discuss 
if solutions helped, if not identify new solutions 
 
Two Months (~15 
min) 
Phone call/ Review monthly MEM report with participant, 
Discussion of Improvements  
 
 
Attention Control 
The attention-control intervention was delivered by the PI at two time points 
utilizing two educational brochures developed by the American Heart Association. At the 
initial home visit, the “Living with Heart Failure” brochure was reviewed, which included 
education on symptoms of heart failure, causes of heart failure, diagnostic tests, 
medications, symptom monitoring, and staying active (Living with Heart Failure, n.d.). The 
participant received a phone call at one week to answer any questions they may have had 
about the education they received. During the one-month phone call, the “Heart Failure: 
Warning Signs of a Flare Up” brochure, which was mailed to participants, was reviewed, 
which includes information on swelling, shortness of breath, and other signs that warrant a 
phone call to the physician (Heart Failure: Warning Signs of a Flare-up, n.d.). The education 
received did not include information about medication adherence. If the participant asked for 
help with taking medications, they were referred to their physician. At the end of the 
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two-month intervention, the PI summarized the education received. The participant 
continued to use the MEMS and the MEMS diary for the one-month maintenance phase and 
then received a phone call to return the MEMS via mail. They were also asked 
feasibility/acceptability questions at the conclusion of study. The PI delivered the attention 
control intervention to all participants and tracked protocol delivery using the protocol 
delivery tracking form (see Appendix H). Participant contacts with descriptions are shown in 
Table 4. 
Table 4 
Attention Control 
Timing Method/Content 
 
Baseline (~1 hr) Home visit/ “Understanding Heart Failure” brochure and education 
 
One month 
(~30 min) 
Phone call/mailed “Heart Failure: Warning Signs” brochure and 
education 
 
Two Months 
(~30 min) 
 
Phone call/summary of all education  
 
Measures 
Data were collected using measures described below to meet the aims of the study.  
Beginning of Screening Phase 
Cognitive status. Mini-Mental Status Exam (see Appendix I) that uses a reliable and 
valid tool (80% sensitivity and 85% specificity) (Tombaugh & McIntyre, 1992) was 
conducted to measure cognitive status to ensure the participant met inclusion criteria. 
Demographics. Demographic information (see Appendix J) was collected at the 
initial visit.  
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Pre- and Post-intervention 
Systems thinking. The Systems Thinking Survey (see Appendix K) was used to 
measure personal system behavior perceptions utilizing a psychometrically sound (test-retest 
0.74, Cronbach Alpha 0.89, discriminate validity 0.01) 20-item survey using a five-point 
Likert Scale (Dolansky & Moore, 2013). This survey has been utilized in previous 
medication adherence intervention studies in kidney transplant and irritable bowel disease 
patients to measure systems thinking pre- and post-intervention (Matteson-Kome et al., 
2014; Russell et al., 2011).  
Heart failure outcomes. Heart failure outcomes were measured pre- and post-
intervention utilizing a Likert 12-item Kansas City Cardiomyopathy Questionnaire (see 
Appendix L) measuring HF health status including symptoms, quality of life, and limitations 
(Cronbach alpha >0.92, test-retest 0.76, validity 0.98). This questionnaire has been used in 
three clinical studies including 4,168 patients (Spertus & Jones, 2015).  
Continuous 
Feasibility. Feasibility was assessed throughout the study in various ways. Examples 
of feasibility tracking includes documenting time it took participants to complete surveys, 
any difficulty understanding the surveys, tracking recruitment, retention, and attrition rates, 
documenting on protocol checklists, and making field notes on all participant interactions.  
Post-intervention Only 
Acceptability. A questionnaire (see Appendix M) with open-ended and dichotomous 
format was administered at the completion of the study to answer research questions related 
to acceptability of the study. Examples of questions on this survey include time, 
inconveniences, suggestions for improvement, and difficulties with using MEMS.  
36 
Dependent Variable: Medication Adherence 
Medication Event Monitoring Caps (MEMS). Medication adherence was 
measured electronically utilizing MEMS caps, which is a computerized monitoring system 
in which a chip is located inside a cap and provides data of the date and time the pill bottle is 
opened (Park et al., 2015). Electronic monitoring is a good method for measuring adherence, 
because it does not rely on recall or self-report which can over-estimate adherence 
(O’Donohue & Levensky, 2006). One flaw to this measurement is that a participant may 
open the bottle and not ingest the medication (Denhaerynck et al., 2008). To correct this 
problem, participants were asked to complete a MEMS diary (see Appendix N) where they 
recorded any accidental openings, openings to refill, or openings to remove pill and take at a 
later time. Participants also recorded dates hospitalized or extra doses of diuretics taken in 
the diary, and these data points were not monitored. MEMS cap data were corrected using 
the MEMS diary. Participants were instructed on how to use the caps and diary using an 
instructional sheet (see Appendix O) and asked during every study interaction if they were 
having any issues or had any questions about the MEMS caps. Participants who used pill 
organizers were aware they could put Tic-Tacs in pill organizers to remind them to open 
their MEMS, which has been found effective in previous studies (Russell et al., 2011). MA 
was measured continuously during the intervention and maintenance phase for both the 
intervention and attention-control group. The formula for calculating medication adherence 
is the percent of prescribed doses taken on time.  
Procedures 
 IRB approval was obtained prior to the start of the study from the University of 
Missouri-Kansas City and Belleville Illinois Community IRB. The Heart Failure Care 
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Coordinator from Memorial Regional Health Services created a list of all patients aged 65 or 
older with a HF diagnosis who were self-administering diuretics following a screening for 
eligibility form (see Appendix P). The Coordinator contacted potential participants and 
followed a telephone script (see Appendix Q) that contained a brief introduction of the 
study, and the patient was asked if the PI could contact him/her. The PI then contacted 
potential participants to discuss the study including study purpose, participant involvement, 
risks and benefits, and the option not to be in the study. The PI answered any questions 
during this phone call. 
If the participant decided to be included in the study, an initial home visit was 
arranged. During this home visit, consent forms were reviewed with the participant and 
signed by the participant. Questions were asked of the participant by the PI to ensure 
inclusion criteria were met, and then demographic data were obtained by the PI. Instructions 
on use of MEMS and MEMS diary were provided, and any participant questions were 
answered. The participant was then instructed to start using the MEMS for their diuretic 
medication, and the screening period began. Participants with adherence rates less than 88% 
after the two-month screening period were randomly assigned by the PI to treatment or 
control groups on a 1:1 ratio using a computer-generated randomization list.  
 Participant confidentiality was maintained by assigning participants a code used for 
identification that was locked in a separate cabinet, removing participant names once code 
was given, and entering all data into password-protected data systems. The PI was 
responsible for all data management, and only the dissertation chair and PI had access to 
data. Participants used the MEMS and MEMS diary for five months and had monthly visits 
or phone calls during the two-month intervention phase.  
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To protect human subjects, all researchers interacting with participants were trained 
when to refer a participant to the clinic or physician. An attention-control group was given 
education instead of no treatment to avoid the risk of ethical concerns that some participants 
were receiving potential treatment effects while others were receiving nothing. Participants 
may have felt uncomfortable if adherence rates were low so study personnel told participants 
about adherence being a common problem for many people. If adherence rates were 
extremely low (<30%), the PI would talk with the participant about the adherence rate and 
suggest they talk with their physician.  
Attrition 
All participants were given a $20 gift card after the screening period. Participants 
entering the intervention phase were given a $10 gift card after the intervention phase and a 
$10 gift card after the maintenance phase. The participants did not have to pay for any 
equipment or instruction materials associated with the study. Participants were provided 
with pre-paid envelopes to return the MEMS caps after each phase of the study. All 
communication occurred either by phone, mail, or home visits or location of participants’ 
choice to reduce participant burden. Length of the study was carefully considered and the 
intervention phase was reduced to two months since the intervention had been found to be 
effective within one month in previous studies (Matteson-Kome et al., 2014; Russell et al., 
2011).  
Data Analysis 
Redcap was utilized for data collection (Harris et al., 2009). All statistical tests were 
conducted using Statistical Package for the Social Sciences (SPSS) version 25 with a 
significance level set to 0.05 (Polit & Beck, 2012). Data analyses were completed by the PI. 
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The PI double entered and verified the data. Data were cleaned by checking for outliers and 
wild codes (Polit & Beck, 2012). Descriptive statistics were calculated for demographics, 
adherence scores, and time duration of surveys and visits (Plichta, Kelvin, & Munro, 2012). 
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CHAPTER 4 
RESULTS 
Recruitment 
Primary Research Question 
What are the recruitment rates in the study? 
Participants were recruited from August 2017 to February 2018 from Memorial 
Regional Health Services. Fifty-five participants were asked to take part in the study but 25 
declined, yielding 30 participants enrolled in the study and a consent rate of 55%.  
Demographic data was not obtained on those who declined because consent to obtain 
demographic data occurred when the PI spoke with the participants, and these 25 
participants told the Heart Failure Care Coordinator they did not want the PI to contact 
them. Reasons given to the coordinator for not enrolling in the study included being 
overwhelmed with current health status or not wanting to be watched. Eleven participants 
did not complete the screening phase, which is discussed in detail later in this chapter.  
Nineteen participants (63%) completed the screening phase. Sixteen participants had 
medication adherence rates greater than 88% during the screening phase (mean=96%), 
therefore exiting the study. Three participants were eligible to be randomized into the 
intervention or attention control group, but only two agreed to continue with the study, 
leaving one participant in each group and yielding a conversion to intervention rate of 7%. 
The participant in the SystemCHANGE™ group did not complete the study; therefore the 
intervention phase attrition rate was 50%. One of 30 participants completed the entire study, 
yielding a recruitment rate of 3% at the end of the study.  Figure 2 depicts the flow of 
participants through the study.   
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Figure 2. Flow of Participants through Study 
Considered 
Participation (N=55) 
Screening 
Enrollment 
  (n=30) 
Randomization 
Non-adherers (n=2) 
SystemCHANGE™ 
(n=1) 
Lost to follow up 
(n=1) 
Analyzed (n=0) 
Analysis 
Follow Up 
Allocation 
Analyzed (n=1) 
 
Lost to follow up 
(n=0) 
 
 Attention Control 
(n=1) 
Screening 
Did not complete screening (n=11) 
 death (n=1) 
 diuretic discontinued (n=1) 
 no longer taking own 
medication (n=2) 
 did not want to complete 
screening (n=3) 
 did not use MEMS correctly 
(n=2) 
 caps not returned (n=2) 
Completed screening (n=19) 
 adherers exited (n=16) 
o 53% of sample 
adherent with mean 
adherence of 96% 
 did not want to move into 
intervention (n=1) 
 
Recruitment rate at end of 
study: 1/30 (3%) 
Consent rate: 30/55 
(55%) 
Conversion to 
intervention rate: 2/30 
(7%) 
Intervention phase 
attrition rate: 1/2 (50%) 
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Eligibility Criteria 
Primary Research Question 
Are the eligibility criteria sufficient or too restrictive? 
After one month of recruiting, only two participants were enrolled in the study, 
making it evident that the inclusion criteria were too stringent. The inclusion criterion with 
the biggest loss of potential participants was the age of 65 or older and having an ejection 
fraction of 40 percent or lower. The age criterion was changed from 65 to 50 to open up the 
study to more participants after one month. After five months of recruiting with only 16 
participants enrolled, the inclusion criterion of having an ejection fraction of 40 or lower 
was changed by eliminating the ejection fraction requirement and instead including anyone 
with the diagnosis of heart failure. The remaining 14 participants were enrolled in one 
month.  
The coordinator found the eligibility screening tool easy to use. The criteria of age, 
heart failure diagnosis, taking diuretics, and hospitalization status were easy to find in the 
electronic health record. The coordinator also was familiar with the participants and knew if 
they administered their own medications, spoke English, and were cognitively intact, which 
was verified by the PI utilizing a Mini-Mental State Exam. 
Demographics 
 This section covers the demographics of the 30 participants enrolled in the screening 
phase of the study. Baseline continuous demographic data is found in Table 5. The average 
age of the participants was 68.1 (SD=8.6), with a range of 54 to 90. Participants’ average 
number of current prescription medications was 10.8 (SD=4.5), with a range of 4 to 22. The 
participants’ average ejection fraction was 33.5 (SD=15.3), with a range of 10 to 65.  
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Table 5 
Demographic Continuous Data 
Variable Mean St. Deviation Range 
Age (years) 68.1 8.6 54-90 
Current prescription 
Medications (number) 
10.8 4.5 4-22 
Ejection Fraction (%) 33.5 15.3 10-65 
 
Baseline categorical demographic data is found in Table 6, including: male 66.7% (20/30), 
African American 66.7% (20/30), high school graduate 26.7% (8/30), and 60% (18/30) 
having an annual income below 25,000 annually. All participants had a cognitive score of 6 
of 6 on the mini-mental status exam, meaning no cognitive impairment was present.  
The two participants who moved into the intervention phase were both African 
American males with a low socio-economic status. The difference between demographics 
was that the participant in the attention control group was married and had a high school 
education, and the participant in the intervention group had never been married and had 
some high school education. The Kansas City Cardiomyopathy scores, where zero equates 
to worst status and 100 to best status in regards to heart failure, revealed that the participant 
in the attention group had a score of 47 both pre- and post-intervention, and the participant 
in the SystemCHANGE™ group had a pre-intervention score of 35. No post-intervention 
score was collected on the participant in the SystemCHANGE™ group, since this 
participant did not complete the study.  
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Table 6 
Demographic Categorical Data 
Variable Total Sample (n=30) 
Male Gender 20 (66.7%) 
Caucasian 10 (33.3%) 
African American 20 (66.7%) 
High School Graduate 8 (26.7%) 
College Graduate 7 (23.3%) 
Married 7 (23.3%) 
Retired 16 (53.3%) 
Annual Income below 25,000 18 (60%) 
Depression 4 (13.3%) 
Sleeping Difficulty 18 (60%) 
 
Medication Adherence Scores 
Exploratory Research Question 
How effective is the intervention in improving medication adherence trends in this 
sample?  
The participant randomized into the SystemCHANGE™ group had a screening 
adherence score of 55%. No further medication adherence data were obtained from this 
participant; therefore medication adherence trends post-intervention could not be observed. 
The participant in the attention control group had a screening adherence score of 45%. 
During the intervention phase the monthly adherence score was 76% at one month, 85% at 
two months, and 63% at the end of the three months.  
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Feasibility of Intervention 
Primary Research Questions 
To what extent can the intervention procedures be implemented correctly? How 
appropriate is the timing and duration of the intervention? to what extent do the participants 
comply with the intervention? 
 The protocol checklist was followed for both the attention control and 
SystemCHANGE™ intervention delivery and implemented correctly for the initial home 
visit. The participant in the attention control group did not ask about help with medication 
taking while in the study. The appropriateness of the timing and the duration of the 
intervention cannot be determined since the only participant in the intervention group did 
not complete the study or comply with the intervention. The initial home visit occurred with 
the intervention participant and the solution of putting medications in the kitchen by the 
phone charger was formulated. After the home visit, numerous attempts to contact the 
participant via phone and mail were unsuccessful.  
Time Demands 
Primary Research Question 
What are the time demands on the participants for completing the survey and visits? 
 This section covers the time of the surveys and visits. The demographic survey 
completed at the beginning of screening took an average of 2.2 minutes (SD=1) to complete, 
with a range of one to six minutes. None of the questions on the demographic survey were 
challenging, according to the participants. The duration of the initial visit in which 
participants were enrolled in the screening phase of the study took an average of 21.8 
minutes (SD=7.7), with a range of 11 to 40 minutes. The duration of the home visit at the 
46 
beginning of the intervention phase was 40 minutes with the attention control participant and 
47 minutes with the SystemCHANGE™ participant. The monthly phone calls with the 
attention control participant totaled 45 minutes in length.   
Attrition 
Primary Research Questions 
What are the attrition rates in the study? What is the extent of missing data? 
 There were 11 participants of the 30 enrolled into screening who did not complete 
the two-month screening phase for a variety of reasons. There was one participant death, 
two participants did not return their caps, two participants were not using their MEMS caps 
correctly and continued using their pillboxes (missing data), three participants no longer met 
criteria (n=1, Lasix discontinued; n=2, no longer administering own medications), and three 
participants did not want to continue the study (n=1, recently hospitalized; n= 1, Lasix dose 
change; n=1, out of medication). There were 19 participants who completed screening, 16 of 
whom were adherent, thereby exiting the study. One participant completed the screening 
phase and was non-adherent (38%) but did not want to move into the intervention phase. 
This yields a conversion to intervention rate of 7% (2/30). The participant randomized into 
the SystemCHANGE™ group did not complete the study. Since only one of the two 
participants in the intervention phase completed the study, the intervention phase attrition 
rate was 50%.  There was no missing data on the demographic survey, Kansas City 
Cardiomyopathy Questionnaire, or Systems Thinking Survey.  
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Challenges of MEMS Caps 
Primary Research Question 
What are the challenges in using the medication event monitoring caps or wireless 
readers? 
 Challenges to using the MEMS caps were assessed through reviewing the one-week 
phone call in which participants were asked if they had any questions about the MEMS caps 
and participant contact field notes. Three participants were confused by the number on top 
of the MEMS cap and why it reset to zero every night. Three participants sent their caps 
back before the two-month screening period was over, one at two weeks and two at seven 
weeks. One participant continued to use their pillbox and opened the MEMS cap at night to 
refill a daily pill box. The wireless readers were to be used during the one-month phone call 
of the SystemCHANGE™ intervention to transmit adherence data to the PI. Since no 
participants made it to this point of the study, no data on the utilization of the readers were 
obtained.  
Acceptability 
Primary Research Questions 
Do participants feel the time spent in the study is too long, too short, or just right? 
What inconveniences does the survey or intervention place on the participant? What are the 
challenges in using the MEMS caps? To what extent do the participants remain blinded? 
Any other suggestions for improving the study? 
 The one participant in the attention control group who completed the entire study 
provided feedback regarding the study using the acceptability questionnaire. When asked 
about the timing of the study, the participant responded, “okay time frame.”  The participant 
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responded “no” when asked about inconveniences of the survey or education intervention. 
The participant thought the MEMS was practical to use, had a positive effect on medication 
taking, and said it was a “good reminder” and that they “liked the number on top of cap, let 
you know if you took your medications or not,” and wanted to continue to use the MEMS. 
The participant responded, “I do not know, couldn’t tell you” when asked if they received 
the SystemCHANGE™ or attention control intervention. The participant’s only suggestion 
for improving the study was measuring more than one medication.  
  
49 
CHAPTER 5 
DISCUSSION 
The purpose of this mixed methods study was to examine the feasibility and 
acceptability of a SystemCHANGE™ intervention on improving medication adherence in a 
highly prevalent population of older adults with heart failure. This study was the first to 
attempt to utilize the SystemCHANGE™ intervention to improve medication adherence in 
the population of older adults with heart failure. Older adults have unique challenges to 
medication adherence such as having complex medication regimens, possible financial 
issues, cognitive decline, and possible need for assistance with medication taking, making it 
important to study this population (Yap et al., 2016). The SystemCHANGE™ intervention 
includes a theoretical underpinning and environmental approach considering one’s routines 
and important people (Alemi & Neuhauser, 2005; Moore et al., 2006), which are lacking in 
previous intervention work (Conn et al., 2016; Yap et al., 2016). This chapter discusses the 
results of the study and how these results compare and contrast with previous literature and 
theory. Strengths and limitations of the study are explored, leading to implications for future 
research.  
Feasibility 
Recruitment of participants was initially slow due to stringent inclusion criteria, but 
after modifications to criteria the desired sample size was obtained. By changing the 
inclusion age from 65 or older to 50 or older and including all types of heart failure, internal 
validity could be threatened (Polit & Beck, 2012). Variations in age and severity of heart 
failure can lead to variations in symptoms, medication side effects, cognition, and number of 
medications, all of which can impact medication adherence (Sabaté, 2003). It is highly likely 
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that the desired sample size could have been obtained with the original inclusion criteria if 
multiple sites had been utilized for recruitment. This would be preferred to increase 
generalizability. There was also a low enrollment consent rate in this study, and due to 
protocol, no demographics were obtained on the patients who declined participation in the 
study. Future studies should explore the demographics of those who did not consent to be in 
the study to see if response bias exists (Polit & Beck, 2012).  In future studies, the 
coordinator recruiting could obtain consent on patients not willing to enroll in the study to 
obtain demographic data only.  
This study attempted to include only non-adherent participants in the intervention 
phase which would prevent the ceiling effect, but could be the reason for the low conversion 
to intervention rate (7%), since 11 participants did not complete screening and could have 
been eligible to move into the intervention based on a mean adherence score of 65.6% in this 
group. In one study 12 participants lost their MEMS cap and reported this was likely the less 
adherent participants (Bouvy et al., 2003). Based on two systematic reviews, only one 
medication adherence intervention study to date has attempted to include only non-adherent 
heart failure patients (Andrews, Russell, & Cheng, 2017; Conn, Ruppar, Enriquez, & 
Cooper, 2016).   
Another important consideration is recruitment and retention barriers of older adult 
and minorities in research studies. Common barriers found in the literature include mistrust 
of research, resources such as transportation, money, and time constraints, cognition, and 
poor health (Luebbert & Perez, 2016; McDougall, Simpson, & Friend, 2015; Michelet, 
Lund, & Sveen, 2014; Polit & Beck, 2012).  In this study, five participants who dropped out 
had a decline in health status and two ran out of medications. Strategies to improve mistrust 
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issues include frequent face-to-face contacts (Polit & Beck, 2012) which occurred in this 
study. Utilizing community partners or an African American representative on the research 
team could also enhance future studies (Luebbert & Perez, 2016). Ways to overcome the 
resource barriers include giving incentives and providing transportation (McDougall et al., 
2015; Michelet et al., 2014) which were both accounted for in this study. Participants were 
given $40 for completing the entire study, and the PI met participants at the location of their 
choice, which included their homes or the clinic following their appointments. Due to 
attrition, only one participant completed the acceptability questionnaire administered at the 
end of the five months. Therefore, the appropriateness of the duration of the study was not 
explored but should be considered in future studies. 
Cognitive impairment, including a decrease in memory and executive function, is a 
common issue in older adults with heart failure due to decreased cardiac function, which 
leads to decreased brain perfusion (Gottesman et al., 2010; Leto & Feola, 2014). One 
adherence intervention study including older adults with heart failure reported many 
participants being too confused to continue in the study (Varma et al., 1999).  The mini-
mental status exam was performed to ensure cognition before enrollment into this study, but 
further cognition screening at multiple time points throughout the study may be beneficial to 
ensure only cognitively intact participants continue in the study.  The SystemCHANGE™ 
intervention is focused on individuals administering their own medications, so cognition is 
important in this study; participants must be able to follow directions.  Another strategy 
would be providing thorough information that is easily understood and utilizing frequent 
reminders such as more frequent phone calls or written instructions. The last barrier to 
consider is patients having a poor health status. Heart failure is progressive with debilitating 
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symptoms, which can impact retention in long term intervention studies (Heart Failure 
Society of America, 2010). Targeting participants in the beginning stages of heart failure 
could be beneficial for interventions to be effective, since symptoms may not be severe and 
cognition may not be impaired. The intervention may increase medication adherence, which 
could delay cognitive decline. When working with participants with more advanced heart 
failure, adaptions need to be made to the study protocol to accommodate for possible 
cognitive impairment and poor health status.  
Lessons Learned 
 The lessons learned from this pilot study include recruitment issues, technology 
challenges, resource utilization, and screening protocol. Recruitment issues in this study 
included challenges to gaining access to the population, recruitment taking longer than 
anticipated, and one person being responsible for recruitment.  Future studies could be 
enhanced by including multiple sites and multiple people helping with recruitment. It is also 
important to ensure the recruiters feel a sense of ownership of the study and have a means to 
provide suggestions and input for the study. Consistent communication between the PI and 
recruiter also can help with motivation of the recruiter (Polit & Beck, 2012).   
 Some participants had challenges with the MEMS caps, such as prematurely sending 
the cap back before two months was completed; confusion was caused by the number 
changing at the top of the MEMS cap. Two participants continued to use pillboxes. Future 
studies can include revisions to protocol to address these fidelity issues. Perhaps a label on 
the MEMS bottle or envelope provided to return the cap could include the date on which to 
return the cap. The envelope to return the cap could also be mailed to participants a few days 
before the MEMS cap is to be returned instead of supplying it during the initial enrollment 
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visit. Future studies could include further assessment of using pillboxes. Instead of simply 
asking participants if they use a pillbox, participants could show the researcher their 
medications, where they are stored, and how they administer the medications. Participants 
could demonstrate using the MEMS cap after education as well to ensure they understand 
instructions. Future studies could also include more instructions about the numbers that 
change on the top of the cap daily to depict the number of times the bottle opened in one 
day. Written instructions in addition to verbal could be provided on the use of MEMS for 
those with decreased memory (Lewis et al., 2017). A meta-analysis found that providing 
one-page succinct written instructions with medication adherence interventions had better 
effects on medication adherence in older adults (Conn et al., 2009).  
 Another important consideration is technology use in the older adult population, 
since medication adherence was measured in this study using MEMS caps. Barriers to 
technology utilization in older adults are related to chronic diseases producing changes in 
cognitive, motor, or sensory function; therefore technology needs to be adapted for this 
population (Fletcher & Jensen, 2015). An additional barrier includes personal attitudes and 
acceptance of the technology.  Although the MEMS cap is perceived as being easy to use, it 
can be intimidating to some. Ways to increase acceptance of using technology include 
having a thorough discussion and training of use and explaining the benefits of the 
technology (Fletcher & Jensen, 2015).   
 Monetary costs, time demands, and personnel requirements can be found in Table 7. 
The cost for mileage and research assistance time in hours was based on average round trip 
mileage and average time spent on phone calls, home visits, and mileage. The total cost per 
participant to go through the screening phase only was $170.20. The total cost per 
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participant to complete screening, the attention control intervention, and the maintenance 
phase was $303.97. The total cost per participant to complete screening, the 
SystemCHANGE intervention, and the maintenance phase was $679.20.  This study had 30 
participants who were screened, one participant completed the attention control intervention 
and maintenance phase, and one participant completed the screening and the home visit. The 
total cost of the study was $5,718.77. 
  
5
5
 
 
Table 7 
Study Cost Breakdown 
 
Variable Costs Phase Cost 
Cost per 1 
Participant in 
Screening
Cost per 1 
Participant in SC
Cost per 1 
Participant 
in AC
Study Cost with 30 
Participants 
(30Screening/1SC/1AC)
Screening $20.00 $20.00 $20.00 $20.00 $600.00
Intervention $10.00 $0.00 $10.00 $10.00 $10.00
Maintenance $10.00 $0.00 $10.00 $10.00 $10.00
Educational Brochures (Attention Control Only) Intervention $2.77 $0.00 $0.00 $2.77 $2.77
Screening $3.20 $3.20 $3.20 $3.20 $96.00
Intervention $5.00 $0.00 $5.00 $5.00 $10.00
Cap and Medication Bottle Screening $81.00 $81.00 $81.00 $81.00 $2,430.00
Wireless Reader (SystemCHANGE ™ Only) Intervention $378.00 $0.00 $378.00 $0.00 $378.00
Screening $36.00 $36.00 $36.00 $36.00 $1,080.00
Intervention $36.00 $0.00 $36.00 $36.00 $72.00
Screening $30.00 $30.00 $30.00 $30.00 $900.00
Intervention $60.00 $0.00 $60.00 $60.00 $120.00
Maintenance $10.00 $0.00 $10.00 $10.00 $10.00
Total Cost $170.20 $679.20 $303.97 $5,718.77
*Fixed Cost of TouchScreen Laptop Additional $310
Research Assistant
Postage
Incentives
Mileage (based on average round trip of 67 miles)
Table 1: Study Cost Breakdown
 56 
The final lessons learned deal with the screening phase of this study. Participants 
were screened for two months using the MEMs cap, and only non-adherent participants 
moved into the intervention phase.  Non-adherence was defined in this study as an 
adherence rate below 88%. A previous research study of 135 heart failure participants found 
that participants with an adherence greater than 88% measured with MEMs caps were less 
likely to be hospitalized and had lower mortality rates over 3.5 years (Wu et al., 2009). In 
this dissertation study, only 7% of the participants converted into the intervention phase, and 
16 of the 30 participants were adherent or had adherence rates greater than 88%. The desired 
adherence rate is 100%, so if the cut point used in this study was changed from 88% to 95% 
four additional participants would have converted into the intervention phase.  There could 
be benefits in helping those with less than perfect adherence scores to strive for perfection to 
help with outcomes.  
Another consideration is whether or not it was necessary to exclude the first month 
of the two months of screening due to the Hawthorne effect, which was noted in previous 
studies to last 30 days (De Geest et al., 2006; Denhaerynck et al., 2007) . The sixteen 
adherent participants in this study who exited after the screening phase had a mean 
adherence rate of 93.875% during the first month of screening and a mean adherence rate of 
96% in the second month, so no Hawthorne effect noted.  The two non-adherent participants 
from the screening phase had a mean adherence rate of 71% during the first month of 
screening and a mean adherence rate of 50% in the second month. Of the 12 participants 
who did not convert to the intervention, the MEMS cap was utilized by three participants for 
seven weeks. The mean adherence rate was 71% during the first month of screening and 
62% in the second month. These five participants did have a higher adherence rate during 
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the first month of screening. A meta-analysis of 53 medication adherence intervention 
studies including non-adherent participants found no evidence of the Hawthorne effect in the 
analysis (Conn et al., 2016).  Due to the small sample of this dissertation study, it cannot be 
determined that the Hawthorne effect was not present, but future studies could consider 
whether or not excluding the first month of screening is necessary. If a participant is non-
adherent at the first month, moving right into the intervention phase could be beneficial and 
possibly prevent attrition, because the participant would start getting attention at that point.   
Strengths 
Strengths of this study include screening for adherence first so only non-adherent 
participants received the intervention to avoid the ceiling effect or the inability to improve 
further (Polit & Beck, 2012). The SystemCHANGE™  intervention has  theoretical 
underpinnings which is not common in medication adherence interventions (Ruppar, 2010). 
Medication adherence was measured objectively using electronic monitoring, which is 
considered reliable and valid because it does not rely on memory or self-report (Bosworth et 
al., 2006).   
Limitations 
Limitations of this study include recruiting from only one site and having a small 
sample size, thereby decreasing generalizability. An additional limitation was a low consent 
rate and not obtaining demographics on those who did not consent. A major limitation in 
this study was that no participants completed the SystemCHANGE™ intervention, and only 
one participant completed the attention control intervention. This limited the ability to 
answer some research questions and provides limited information for future studies.  
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Implications for Future Research 
Now that the feasibility, lessons learned, strengths and limitations of this study have 
been explored, directions for future research will be discussed. More pilot testing is needed 
on this population prior to a fully powered study to target time and resources more 
efficiently. Utilizing multiple sites can help with recruitment and generalizability. It would 
be important to collect data on those who did not consent to be in the study. Further 
knowledge can be gained through qualitative interviewing of participants who dropped the 
study to determine what the barriers to the study were to adapt in future studies. To address 
mistrust issues, having members of the research team who represent the population could be 
beneficial as well as meeting in groups in the community (Luebbert & Perez, 2016). 
Cognitive status must also be considered and assessed throughout the study. Education given 
to participants should be adapted to the cognitive status and the health literacy level of the 
population. One study found low health literacy levels in African Americans with heart 
failure, leading to misunderstanding information (Dickens, Lambert, Cromwell, & Piano, 
2013). Education should focus on addressing MEMS challenges previously discussed and 
technology acceptance. Changes could be made in future studies in regards to the adherence 
cut point and shortening the screening phase.  
Conclusion 
 In conclusion, the feasibility and acceptability of the SystemCHANGE™ 
intervention on improving medication adherence in older adults with heart failure was 
explored. Due to a high attrition rate and no participants completing the intervention, it is 
obvious that the research protocol needs major revisions to recruit and retain the proposed 
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population. Further qualitative work can lead to a greater understanding of barriers and 
facilitators to participation in a research study of this nature.  
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APPENDIX A 
DESIGN DIAGRAM  
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APPENDIX B 
SC PROTOCOL CHECKLIST 
ECHO SystemCHANGE Protocol Checklist  
Key Components Completed Partially 
Complete 
Not 
Completed 
Materials: Stylus, magnifying glass, Binder, tablet 
Binder: 
 hard copy of Systems thinking and KCCQ 
 MEMS diary 
 Intervention forms: imp people, routines, life 
cycles, possible solutions 
 MEMS report from screening 
   
Getting Seated 
 Ask if you can sit at a table where you can 
easily work together with the laptop and 
paper forms  
NA   
Introductions (5 mins) 
 RA will begin by introducing herself, 
including where she grew up, her family 
status (children, spouse, 
parents/grandparents), hobbies, and her work 
as a nurse 
 Angela Andrews- grew up in Bethalto IL, 
married with one year old, enjoy crafting and 
baking cupcakes, worked as nurse at 
Belleville Memorial for 7 years teaching at 
SIUE currently 
 The Pp is asked to introduce him/herself 
addressing where she grew up, family status, 
and hobbies/interests  
NA   
Set up Wireless Reader (5 mins) 
 Ask the Pp for a place to plug in the Wireless 
Reader and plug it in 
 Explain that you will review it later 
 Show the Wireless Reader to Pp (don’t go 
into detail about the 3 lights) 
 Tell them they will use this to send their 
MEMS information each month to us 
 Ask them where they would like to have this 
plugged in 
 Plug it in and tell them we will call them on 
the phone and walk them through the steps 
NA   
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ECHO SystemCHANGE Protocol Checklist  
 Show them how to set the MEMS on the 
Reader and tell them it turns blue when it is 
working 
Introduce Surveys (20 mins) 
 The first part of the study involves taking 2 
surveys on the tablet. This will take about 10 
minutes.  
 You can read and complete the surveys or I 
can read them to you and you point to your 
answer. Which would you prefer? 
 There are no right or wrong answers to these 
surveys.  
 Open the Kansas City Cardiomyopathy 
Questionnaire  
 Read “This questionnaire refers to your heart 
failure and how it may affect your life. Read 
and complete the questions” 
   
 Open the System Thinking Scale 
 Read “Please read each of the statements and 
indicate the frequency of agreement with the 
statement about when I (you) want to make 
any improvement in your life....” 
   
Tell the Pp these surveys will be repeated in 2 
months 
   
Review SystemCHANGE slides 
 I’d like to tell you about the intervention that 
we are going to work together on to improve 
your medication taking. It is called 
SystemCHANGE. 
 Review slides 
 Ask them if they have any questions  
 Use the teach-back method to check for 
understanding; say “To make sure I’ve done 
a good job of explaining this to you, tell me 
in your own words what SystemCHANGE 
is”. 
 Leave the slides with the Pp to place on the 
refrig with the MEMS report  
   
Review the MEMS Report 
 This is a report that shows your medication 
taking from the MEMS cap for the past 1 
month 
 You used the MEMS cap for 2 months 
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ECHO SystemCHANGE Protocol Checklist  
however studies have shown the most recent 
1 month are a better example of how you 
really take your medications 
 Let me help you understand this report 
a. The MEMS is monitoring [name 
medication] and your medication 
taking times are [name am times]  
b. Your adherence score is [read their 
score] 
   
c. Number of days monitored (30)    
d. Calendar(s): 
i. Blue boxes are days dose of 
medication was taken 
correctly 
   
ii. Gray boxes indicate if 0 doses 
were taken. 
   
e. Graph Information: 
i. Days (x-axis[horizontal]) 
   
ii. Times (y-axis[vertical])    
iii. Blue dots 
iv. Each time MEMS cap was 
opened and medication taken 
(presumably) 
   
f. Graph Information top of page 2: 
i. Red Triangles 
ii. Missed doses 
iii. Gray Bar 
iv. When doses are missed 
   
v. Blue Bar 
vi. Both doses were taken 
   
g. Number of 2 or more consecutive 
days treatment was interrupted. 
   
h. Ask “What is your adherence goal?” 
i. Help the Pp understand the goal 
should be 100% and you can help 
them reach that goal 
   
j. Only use positive statements when 
reviewing the MEMs report (ie. 
“Opportunities for improvement” “it 
is not your fault” “habits can hinder” 
“system is not working” “It is okay, 
this is why I am here to work on this 
together”) 
   
Introduce Important People Form    
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ECHO SystemCHANGE Protocol Checklist  
 Part of using SystemCHANGE to improve 
your medication taking is to consider 
whether there are any important people who 
help you with our medication taking. 
 Is there anyone who helps you take your 
meds each day? 
 If a pillbox is used-Does anyone help you set 
up your pillbox? 
 Is there anyone who helps you get your med 
refills? 
 If no to all of these questions, skip the 
Important People form- “it sounds like you 
are independent with your medication 
taking” 
 If yes to any of these questions, complete 
form. 
Introduce the Life Routines Form 
 Part of using SystemCHANGE to improve 
your medication taking is to look at your 
daily routines and habits 
 We also want to write down the times of 
your daily routines and habits 
 Repeat back and give times instead of having 
them repeat  
   
Introduce the Life Cycles Form 
 Part of using SystemCHANGE to improve 
your medication taking is to take a close look 
at your routines and habits that happen right 
before and after you should be taking your 
medications 
 We also want to write down the times of 
those routines and habits 
 Review their routines/habits and see if there 
is a place where they can place their 
medications so the meds are right in front of 
them when they are doing another 
routine/habit in the morning  
 We want to use your old routines and habits 
to come up with a couple of ideas of how to 
take your medications that works with the 
routines you already have. 
 *let them come up with suggestions first* 
   
Introduce the Possible Solutions Form    
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ECHO SystemCHANGE Protocol Checklist  
 Now that we have an idea about how to 
improve your medication taking, let’s see if it 
scores well as a possible SystemCHANGE 
solution.  
 There are no right or wrong answers.  
 Possible Solutions Scale (completed by 
patient): 
 
Wording: 
“Here is a tool to help you think about 
(possible solution) in terms of whether it is 
more like a systems idea (point to systems 
oriented words) or more like a personal 
effort/motivation idea (point to personal 
effort/motivation). Thinking about [possible 
solution], place a mark where you think your 
solution falls. Is it more towards systems or 
more towards personal effort/motivation?” 
 
Then after the patient answers the scale tell 
them: "As we discussed earlier, a systems 
oriented solution is more likely to success 
than personal effort/motivation because it 
makes your medication taking an effortless 
habit.” 
 
 If there is no important person, the possible 
solution can be implemented immediately 
(no need to wait 1 week for them to talk to 
important person). The RA will still call in 1 
week to confirm that the solution was 
implemented (Possible Solutions Follow-Up 
Form). 
 Determine a date of when the solution will be 
started.  
 If there is an important person, then the Pp 
needs to discuss the possible solution(s) with 
that important person, and the RA will call in 
2 weeks to find out which solution they 
decided to implement and when it will 
be/was implemented (Possible Solutions 
Follow-Up Form). 
Storyboard    
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ECHO SystemCHANGE Protocol Checklist  
 Give them a magnetic clip 
 Tell them to place the SystemCHANGE 
slides and their MEMS report on their 
refrigerator using this clip 
 Encourage them to share their medication 
taking improvements with their family and 
friends! 
Explain to the participant that he/she will continue to 
use the MEMS cap that was used in the screening 
phase 
 Select diuretic medication to be place in 
MEMS pill bottle (normally same pill used 
during screening period so as not to confuse 
participant).  
 Explain use of TicTacs again, if needed 
   
Introduce New MEMS Diary  
 Here is another MEMS Diary to keep next to 
your MEMS cap as you did in the screening 
phase. 
 Make a note of the date, time, and reason if 
you open the bottle and don’t take a 
medication. 
 This will help us correct the MEMS 
information when we get the cap back. 
   
Set up Wireless Reader (5 mins) 
 Show the Wireless Reader to Pp (don’t go 
into detail about the 3 lights) 
 Tell them they will use this to send their 
MEMS information each month to us 
 Tell them we will call them on the phone and 
walk them through the steps 
 Show them how to set the MEMS on the 
Reader and tell them it turns blue when it is 
working 
   
Whether or not the Pp needs to talk to their Person 
Important to Medication Taking, arrange a time for 
R.A. to telephone Pp in 1 week to review and/or 
discuss any questions related to the home visit 
   
End the Visit 
 Thank them for their participation. Tell them 
how much this will help future HF patients 
so we can better help them with medication 
taking. 
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ECHO SystemCHANGE Protocol Checklist  
 Remind them they will receive a $10 gift 
card in the mail in two months and at end of 
study if they continue to use the MEMS cap 
to thank them for their time. 
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APPENDIX C 
IMPORTANT PEOPLE FORM 
(Adapted from Alemi, Pawloski, & Fallon, 2003) 
 
Important People Form 
Name of person (first name/relationship to you):  Yes No 
1. Does this person keep house with you?   
2. Do you need to consider this person’s schedule when you are 
deciding the best time to take your medications? 
  
3. Does this person help you in carrying out daily living activities 
(bathing, eating, cleaning, washing clothes, commuting, etc.)? 
  
4. Can this person’s decisions affect time, medication availability, or 
other resources needed for taking your medications? 
  
5. Does this person’s decision affect whether your medications are 
available for you to take? 
  
6. Do you see each other on a daily basis?   
7. Does this person affect how and when you socialize with others?   
 Total number of yes responses:   
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APPENDIX D 
LIFE ROUTINES FORM 
(Adapted from Alemi et al., 2003) 
 
Life Routines Form 
Repeat time 
(daily, weekly, 
monthly, other) 
Routine (include any event that 
repeats over time, even if not 
at specific periods) Impact on medication taking 
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APPENDIX E 
CYCLES FORM 
(Adapted from Alemi et al., 2003) 
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APPENDIX F 
POSSIBLE SOLUTIONS FORM 
(Adapted from Alemi et al., 2003) 
 
Step 1: List ideas for changing the environment to improve medication taking.  
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
 
Step 2: Ask these questions of each idea that you have listed above. Give that idea 
one point for each of these questions that you answer “yes” to.  
1. Focuses on events that happen before taking my medications on time. 
2. Does not rely on my motivation or commitment. 
3. Changes my environment. 
4. Once done, stays done. No need to make the change again. 
5. If it fails to improve medication taking, it is no one’s fault. 
6. If it fails to medication taking plans, no point in trying to do it again and harder.  
7. It will increase the time between medication taking failures. 
8. It does not rely on my memory to take medications. 
9. Indirectly improves medication taking and timing. 
10. It is a change in a recurring life routine. 
11. Requires more than one person to bring it about. 
12. If done today, it will improve medication taking in the future, not today. 
13. Leads to timely medication taking as part of another task. 
14. Involves a physical change. 
15. Provides resources (time, equipment) for timely medication taking. 
16. Changes who I spend time with. 
17. Affects others who live with me. 
18. Changes what I do for fun and social gatherings. 
19. Leaves no choice but to take medications on time. 
20. Changes a group activity. 
21. If it fails to work, it gives me new insights about what to do next. 
22. Rearranges the sequence of my daily living activities. 
Step 3: Select the idea with highest number of points to prioritize for action. 
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APPENDIX G 
INTERVENTION STEPS 3-4 
Tell me what you are learning about medication taking? 
Do you think that changes to your routines that you have made are changing your 
medication taking? 
Do you need to make other change to your medication taking routines? 
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APPENDIX H 
EDUCATION PROTOCOL CHECKLIST  
ECHO Educational Protocol Checklist 
Key Components Completed Partially 
Complete 
Not 
Completed 
Materials: Stylus, magnifying glass, educational 
pamphlets, tablet 
Make sure you have with you: 
 Paper (hard copy) RedCap forms for 
backup- Systems Thinking and KCCQ 
 Participants individual MEMS cap from the 
screening phase and bottle 
 MEMS diary  
 Educational booklet “Living with Heart 
Failure” 
 Extra pens, paper, clipboard  
 Cell phone 
 Outline/Script for first educational booklet 
“Living with Heart Failure” 
   
Getting Seated 
 Ask if you can sit at a table where you can 
easily work together with the laptop and 
paper forms  
NA   
Introductions (5 mins) 
 RA will begin by introducing herself, 
including where she grew up, her family 
status (children, spouse, 
parents/grandparents), hobbies, and her 
work as a nurse 
 Angela Andrews- grew up in Bethalto IL, 
married with one year old, enjoy crafting 
and baking cupcakes, worked as nurse at 
Belleville Memorial for 7 years teaching at 
SIUE 
 The Pp is asked to introduce him/herself 
addressing where he/she grew up, family 
status, and hobbies/interests  
NA   
Give an overview of the patient education 
intervention 
 Home visit today where educational 
material will be reviewed 
 Call in two weeks to answer any questions  
 Mailing of educational booklet at one 
month and phone call to discuss content 
NA   
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ECHO Educational Protocol Checklist 
Key Components Completed Partially 
Complete 
Not 
Completed 
 Phone call in two months to summarize 
education and repeat surveys 
Introduce Surveys (10 mins) 
 The first part of the study involves taking 2 
surveys on the tablet. This will take about 
10 minutes.  
 You can read and complete the surveys or 
I can read them to you and you point to 
your answer. Which would you prefer? 
 There are no right or wrong answers to 
these surveys.  
 Open the Kansas City Cardiomyopathy 
Questionnaire  
 Read “This questionnaire refers to your 
heart failure and how it may affect your 
life. Read and complete the questions” 
   
 Open the System Thinking Scale 
 Read “Please read each of the statements 
and indicate the frequency of agreement 
with the statement about when I (you) 
want to make any improvement in your 
life....” 
   
Tell the Pp surveys will be repeated in 2 months    
Discuss the first educational brochure “Living with 
Heart Failure”. Read and review the highlighted 
statements in the brochure. (20 mins)  
*If patients asks about medication adherence 
refer to physician 
   
Explain to the participant that he/she will 
continue to use the MEMS cap that was used in 
the screening phase 
 Diuretic medication to be place in MEMS 
pill bottle (normally same pill used during 
screening period so as not to confuse 
participant).  
 Explain use of TicTacs again, if needed 
   
Introduce New MEMS Diary 
 Here is another MEMS Diary to keep next 
to your MEMS cap as you did in the 
screening phase. 
 Make a note of the date, time, and reason 
if you open the bottle and don’t take a 
medication. 
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ECHO Educational Protocol Checklist 
Key Components Completed Partially 
Complete 
Not 
Completed 
This will help us correct the MEMS information 
when we get the cap back. 
End the Visit 
 Thank them for their participation. Tell 
them how much this will help future heart 
failure patients so we can better help 
them with medication taking. 
 Remind them they will receive a $10 gift 
card in the mail in 2 months & at end of 
study in 3 months to thank them for time. 
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APPENDIX I 
6-ITEM MENTAL STATUS SCREEN 
(Adapted from Callahan et al., 2002) 
 
 
I am going to mention three thing to you: apple, table, penny. 
 
Now I’d like to ask you several questions: 
1. What day of the week is it? 
2. What month is it? 
3. What year is it? 
 
Thank you.  
 
Now I’d like for you to tell me the three things that I mentioned to you earlier.  
4. Apple 
5. Table 
6. Penny 
 
Scoring: The participant receives 1 point for each correct answer in questions 1-3 and 1 
point for each of the three things that are recalled for a total score of 6. If 3 or more 
questions are missed, the participant does not meet inclusion criteria.  
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APPENDIX J 
DEMOGRAPHIC INFORMATION FORM  
1. Gender: male=0; female=1 
2. Ethnicity: Caucasian=0; African American=1; Hispanic=2; Asian=3; Non-Hispanic 
Multiracial=4; other=5 
3. Education Level: grade school=0; some high school=1; high school=2; some college=3; 
college graduate=4 
4. Marital Status: married=0; divorced=1; never married=2; living with someone=3 
5. Employment Status: employed full time=0, employed part-tine=1, disabled=2, 
unemployed=3 retired=4  
6. Income: 0= 1-$25,000, 1=$25,000-$50,000, 2=$50,000-$100,000, 3=> $100,000  
7. Number of current prescribed medications (excludes vitamins, over the counter 
medications): 
8. Do you currently have depression? No=0: yes=1 
9. Do you currently have issues with sleeping? No=0; yes=1  
 
 
 
Evaluation of Form:  
Time Taken to Administer Survey (in minutes): __________________  
Did you have any difficulty understanding any of the questions that were asked? Yes No  
If yes, which ones did you have difficulty understanding?  
Please suggest how the question(s) could have been asked so that they were clearer to you.  
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APPENDIX K 
SYSTEMS THINKING SCALE  
Instructions: 
Please read each of the statements and place an “x” in the answer box that indicates the 
frequency of agreement with the statement: 
 
When I want to make an 
improvement: 
 
Never Seldom Some of 
the time 
Often Most of 
the time 
1. I seek everyone’s view of the 
situation. 
 
     
2. I look beyond a specific event to 
determine the cause of the problem. 
 
     
3. I think understanding how the chain 
of events occur is crucial. 
 
     
4. I include people in my family to 
find a solution. 
 
     
5. I think recurring patterns are more 
important than any one specific 
event. 
 
     
6. I think of the problem at hand as a 
series of connected issues. 
 
     
7. I consider the cause and effect that 
is occurring in a situation. 
 
     
8. I consider the relationships among 
people in my environment. 
 
     
9. I think that systems are constantly 
changing. 
 
     
10.  I propose solutions that affect the 
environment, not specific people. 
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When I want to make an improvement: 
 
 
Never Seldom Some of 
the time 
Often Most of 
the time 
11. I keep in mind that proposed changes 
can affect the whole system. 
 
     
12.  I think more than one or two people 
are needed to have success. 
 
     
13.  I keep my goals in mind. 
 
     
14.  I think small changes can produce 
important results. 
 
     
15.  I consider how multiple changes 
affect each other. 
 
     
16.  I think about how different people 
might be affected by the improvement. 
 
     
17.  I try strategies that do not rely on my 
or others memory. 
 
     
18.  I recognize system problems are 
influenced by past events. 
 
     
19.  I consider the past history and culture 
of my family.  
 
     
20. I consider that the same action can 
have different effects over time, 
depending on the state of the system. 
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APPENDIX L 
KCCQ SPERTUS & JONES 2015 (License Obtained) 
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APPENDIX M 
ACCEPTABILITY QUESTIONNAIRE 
 
1. Tell me what you think of the MEMS caps.  
 
2. Do you think that the MEMS caps had a negative, neutral or positive effect on your 
medication taking routine? Describe this to me.  
 
3. How practical do you think using the MEMS on a daily basis was for you? Describe what 
you mean.  
 
4. Describe any instances when you think using the MEMS as directed was difficult 
 
5. Do you feel the time spent in the study was too long, too short or just right? 
6. Describe any inconveniences of the surveys 
7. Describe any inconveniences of the intervention/education  
8. Do you think you received the intervention? 
9. Any other suggestions for improving the study? 
 
 
 
 
 
Evaluation of Form:  
Time Taken to Administer Survey (in minutes): __________________  
Did you have any difficulty understanding any of the questions that were asked? Yes No  
If yes, which ones did you have difficulty understanding?  
Please suggest how the question(s) could have been asked so that they were clearer to you. 
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APPENDIX N 
MEDICATION EVENT MONITOR (MEMS) DIARY 
 
Write down any time that you accidentally open the MEMS, if you don’t get the 
MEMS cap on tight, if you remove pills before time to take them, or any other 
situation that you think we should know about. This is very important so that 
we know when your MEMS may have been opened when you didn’t take a pill. 
This diary will need to be returned to us when you return your MEMS caps. 
 
Date Time Explanation of what 
happened  
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APPENDIX O 
MEMS EDUCATION 
Script for MEMS Pill Bottle Training 
1. This is the MEMS cap and bottle. The cap has a small electronic chip 
in the top that records the date and the time the cap is removed when 
you take your medicine.  
 
2. Please remove the cap from the MEMS bottle. This is not a child 
resistant cap. You will just simply twist the cap off.  
 
3. The small screen on top of the cap will display a number that 
represents how often you have opened the bottle that day. For 
example, after you open the bottle for your morning diuretic medication 
you should see a number “1” on top. At midnight the MEMS cap will 
reset to “0” ready to record for the next day. This will help you know if 
you’ve take your medicine from the MEMS bottle or not. 
 
4. You will put your diuretic medications that you take once a day into the 
MEMS pill bottle and for the next 2 months you will take your medicine 
from the MEMS bottle. The cap will monitor when you opened the pill 
bottle and took your medicine.  
 
5. There may be times when you open the MEMS but don’t take a pill, for 
example if you are refilling your bottle or taking your medicines out 
early to take later. You will use the MEMS Diary Form for the times you 
open your bottle but did not take a pill. For example, if you are going 
out for the morning and put your meds in your purse or pocket you 
would make a note of the date, time and the explanation of why you 
remove the medicine early. This form is very important and will need to 
be returned with the MEMS pill bottle at the end of this study. Please 
keep the MEMS Diary Form with your MEMS pill bottle. 
 
6. Do you use a pillbox for your medications? If yes, here are some Tic-
Tacs. You can place them in your pillbox at the day and time you take 
your _____ (name of medicine going in the MEMS). These Tic-Tacs 
will remind you to take a pill from your MEMS bottle so you don’t forget. 
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7. You must put your diuretic medication in the MEMS pill bottle. You 
cannot keep it in the pill box and then open and close the MEMS pill 
bottle as if you were taking the medication. We call this “triggering the 
MEMS” and you cannot do this because it will not document your 
medication taking correctly. 
 
8. If you would like you can write the name of your diuretic medication 
and any other details on the pill bottle with the black felt tip pin. Please 
do not write on the cap. 
 
9. Do you have any questions? 
 
10. I will call you in 1 week to check on your progress, please feel free to 
contact me if you have any questions. 
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APPENDIX P 
ECHO STUDY SCREENING FOR ELIGIBILITY FORM 
 
Case Coordinator Screening 
 
1. Date of Birth (at least 50 years of age and older): ________(mm/dd/year) 
2. HF diagnosis confirmed by ejection fraction less than 40%? Yes______ No______ 
3. Most recent ejection fraction: _________ 
4. Takes one diuretic medication? Yes______ No _________ 
5. Administers diuretic medications to self? Yes______ No________ 
6. Not currently hospitalized? Yes_____ No_______ 
 
Contact Information 
Phone Number: ____________________ 
 
Student Investigator Screening 
1. Able to open a MEMS cap as assessed by the investigator asking if there is any 
problem with opening pill bottle caps? Yes _________ No________ 
2. Able to speak, hear, and understand English as determined by the ability to 
participate and comprehend conversation about potential inclusion in the study? Yes 
______ No ________ 
3. No cognitive impairment as determined by a score of 4 or above on the Six-Item 
Cognitive Screening? Yes _______ No ______ Score:_________ 
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APPENDIX Q 
PHONE SCRIPT 
Angela Andrews, a PhD Student at the University of Missouri in Kansas City, is recruiting 
interested people into a study to try to find out what works best to help people who have 
heart failure take their medicines. The study would be about 5 months in length, with no 
extra trips to the clinic, and you could receive up to $40.00 to thank you for your time in the 
study. May I give Angela your name and telephone number so she can call you and explain 
the study in further detail?  
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